United States · FDA National Drug Code directory
LISDEXAMFETAMINE DIMESYLATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-354_2e13240a-a704-4e8e-8fd7-58caab9b9035
- Product NDC
- 31722-354
- Form
- CAPSULE
- Composition / generic term
- Lisdexamfetamine dimesylate
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240909
- Source listing expiry
- 20271231
Source-listed ingredients
- LISDEXAMFETAMINE DIMESYLATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (31722-354-01) · 31722-354-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →